Mounjaro Users Report Hair Loss, Confidence Issues Amid Weight Loss

Mounjaro, a weight loss drug initially developed for type 2 diabetes, has seen rapid adoption in the UK, with 220,000 people expected to use it via the NHS over the next three years. While many users have experienced significant weight loss, several side effects have emerged, including common gastrointestinal issues and hair loss, which has caused distress and self-confidence challenges among some. Users report hair loss beginning around the third month of treatment, often coinciding with rapid weight loss, with hair regrowth occurring as weight loss stabilizes. Another notable side effect reported is a reduced desire for alcohol, with some users feeling physically ill at the smell or taste of alcoholic beverages. Additionally, many users describe a challenging 'slow middle' phase in their weight loss journey where visible progress stalls, leading to feelings of frustration and unfamiliarity with their changing bodies. These experiences highlight the complex physical and emotional impacts of Mounjaro beyond its weight loss benefits.